Welcome Dr Åsa Rosenquist

A few years ago, when west Africa was plagued by an devastating Ebola outbreak, we tried out our protein inhibitors on the Ebola virus. We were delighted when we realized we’d found a group of substances that not only effectively killed the the Ebola virus, but also a range of other viruses as well. Our data […]

Our metabolic target MTHFD2 crystal structure now resolved with inhibitor

The MTHFD2 protein is uniquely expressed in cancer and not in normal tissue. Yet, it is required for survival in cancer, but not for normal cells. This makes it a highly interesting target, with the potential of finding compounds that selectively kill cancer cells, but not normal cells. Key to success is to determine the […]

Helleday Lab congratulates Oskar Fernandez-Capetillo and Dana Branzei becoming new EMBO members

Today Oskar Fernandez-Capetillo and Dana Branzei were elected as members into the prestigious EMBO organisation, which is an organization of more than 1700 leading researchers that promotes excellence in the life sciences. The major goals of the organization are to support talented researchers at all stages of their careers, stimulate the exchange of scientific information, […]